CN1387889A - Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis - Google Patents

Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis Download PDF

Info

Publication number
CN1387889A
CN1387889A CN 02113187 CN02113187A CN1387889A CN 1387889 A CN1387889 A CN 1387889A CN 02113187 CN02113187 CN 02113187 CN 02113187 A CN02113187 A CN 02113187A CN 1387889 A CN1387889 A CN 1387889A
Authority
CN
China
Prior art keywords
chinese medicine
atrophic gastritis
spleen
gastritis
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 02113187
Other languages
Chinese (zh)
Other versions
CN1242800C (en
Inventor
王志强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Shenlu Shuanghe Pharmaceutical Co Ltd
Original Assignee
Hefei Shenlu Shuanghe Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4742493&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1387889(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hefei Shenlu Shuanghe Pharmaceutical Co Ltd filed Critical Hefei Shenlu Shuanghe Pharmaceutical Co Ltd
Priority to CN 02113187 priority Critical patent/CN1242800C/en
Publication of CN1387889A publication Critical patent/CN1387889A/en
Application granted granted Critical
Publication of CN1242800C publication Critical patent/CN1242800C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to Chinese medicine compounding technology and aims at providing one Chinese medicine preparation for treating spleen and stomach Yin-deficiency type atrophic gastritis in obvious curative effect and less toxic side effect. The Chinese medicine preparation has the material composition including Codonopsis Pilosulae, dry organe peel, Chinese yam, ginger, figwort and other six kinds of Chinese medicinal material. It is in two forms of capsule and granule. It has obvious treating effect to chronic superficial gastritis and atrophic gastritis.

Description

The Chinese medicine preparation of treatment deficiency of spleen and stomach Yin type atrophic gastritis
Technical field: the invention belongs to the Chinese medicine complex preparation, particularly a kind of Chinese medicine preparation for the treatment of deficiency of spleen and stomach Yin type atrophic gastritis.
Background technology: atrophic gastritis is a kind of of chronic gastritis, because the conversion ratio of its gastric cancer is higher, so often be counted as the cercinoma prophase pathologic change of gastric cancer.Therefore, atrophic gastritis is the disease of a kind of serious harm health and safety.According to the theory of the traditional Chinese medical science " dialectical executing controlled, YIN and YANG in a relative equilibrium ", but the atrophic gastritis medicine typing is deficiency of spleen and stomach Yang type and deficiency of spleen and stomach Yin type.The tcm diagnosis standard of deficiency of spleen and stomach Yin type atrophic gastritis is: type of deficiency of stomach yin stomachache, burning pain in the epigastrium, xerostomia happiness are cold, appetite stimulator, constipation with dry stool, upset in the stomach, few, the thready pulse of red tongue tongue.At present, the medicine that is used for the treatment of chronic gastritis is a lot, as MOLUO DAN, WEIFUCHUN, SANJIU WEITAI etc., though all have certain curative effect, do not control because it carries out the medicine typing opinion, so be difficult to suit the remedy to the case, therefore, its therapeutic effect is not quite desirable, and curative effect is not high.
Summary of the invention: technical problem to be solved by this invention is: according to the traditional Chinese medical science " dialectical medication ", the theory of " suiting the remedy to the case ", chronic gastritis is carried out medicine typing opinion control, a kind of Chinese medicine preparation of evident in efficacy, the stable and treatment deficiency of spleen and stomach Yin type atrophic gastritis that has no side effect is provided.
Its technical scheme is: a kind of Chinese medicine preparation for the treatment of deficiency of spleen and stomach Yin type atrophic gastritis is characterized in that its raw material components percentage by weight is:
Radix Codonopsis 5-15 Pericarpium Citri Reticulatae 4-12 Rhizoma Dioscoreae 5-15 Rhizoma Zingiberis 1-5
Radix Scrophulariae 5-15 Fructus Mume 7-16 Radix Glehniae 5-15 Rhizoma Polygonati (steaming) 5-15
The Rhizoma Atractylodis Macrocephalae (stir-fry) 5-15 Fructus Crataegi (stir-fry) 5-15 field dobber (decocting a drug wrapped) 5-15
Radix Codonopsis, Rhizoma Dioscoreae, Rhizoma Polygonati QI invigorating are set upright and are principal agent in the side, and the regulating immunological function microcirculation improvement is repaired gastric mucosa, and the atrophy body of gland is had restitution.The Rhizoma Atractylodis Macrocephalae can anti-helicobacter pylori, suppresses bile reflux, strengthens the merit of holding up the spleen stomach reinforcing.Fructus Mume, Fructus Crataegi are promoted the production of body fluid aid digestion, two-ways regulation gastric acid secretion function.The hot-tempered product of Radix Scrophulariae, Radix Glehniae, field dobber isothermal form nourishing YIN can supplementing QI and nourishing YIN.
This preparation is production technology routinely, can make two kinds of dosage forms of capsule and electuary respectively, so that take.
This preparation has the merit of anti-inflammatory and antalgic, stomach reinforcing QI invigorating, strengthening the body resistance; gastric mucosa and anti-gastric mucosa injury had tangible reparation, protective effect; the gastritis model that freund adjuvant is caused has therapeutical effect preferably; lesion degrees such as gastric mucosal erosion, chronic inflammation cellular infiltration, hyperemia are alleviated or the incidence rate minimizing; alleviate and recover the atrophy of gastric gland body, improve stomach and secrete acid, facilitating digestion liquid and digestive enzyme secretion; strengthen gastric motility, strengthen and recovery immunity.
Be the patient of deficiency of spleen and stomach Yin type chronic superficial gastritis and atrophic gastritis through 60 examples are clarified a diagnosis, be divided into two groups at random, take capsule and electuary (its dosage and contain the crude drug amount suitable) respectively.Capsules group 30 examples, wherein atrophic gastritis 16 examples have 6 examples to observe half a year, superficial gastritis 14 examples; The oldest 62 years old, minimum 24 years old; The course of disease is the shortest 10 months, and is the longest 20 years, electuary group 30 examples, and wherein atrophic gastritis 15 examples have 7 examples to observe half a year, superficial gastritis 15 examples; The oldest 61 years old, minimum 26 years old, the course of disease is the shortest 6 months, and was the longest 14 years.Its symptom total effects sees Table 1.
Table 1
The example number Produce effects Effectively Invalid Total effective rate (%)
Capsules group electuary group ????30 ????6 ????20 ????4 ????86.67
????30 ????5 ????21 ????4 ????86.67
Its sick curative effect of planting sees Table 2.Table 2
Superficial gastritis Atrophic gastritis
Two months Two months Six months
Capsules group The electuary group Capsules group The electuary group Capsules group The electuary group
The example number ????14 ????15 ????16 ????15 ????6 ????7
Produce effects ????3 ????3 ????3 ????2 ????2 ????1
Effectively ????10 ????10 ????10 ????11 ????3 ????5
Invalid ????1 ????2 ????3 ????2 ????1 ????1
Total effective rate (%) ????92.85 ????86.67 ????81.25 ????86.67 ????83.33 ????85.71
Its cardinal symptom curative effect sees Table 3.Table 3
The example number Produce effects Effectively Invalid Total effective rate (%)
Gastric cardialgia The electuary group 29 ?11 ?14 ????4 ??86.21
Capsules group 30 ?13 ?14 ????3 ??90
Desire for cold drinks The electuary group 22 ?8 ?10 ????4 ??81.82
Capsules group 23 ?10 ?10 ????3 ??86.96
Dry mouth and tougue The electuary group 26 ?10 ?13 ????3 ??88.46
Capsules group 27 ?13 ?10 ????4 ??85.19
Feverish sensation in the palms and soles The electuary group 20 ?8 ?9 ????3 ??85
Capsules group 20 ?10 ?8 ????2 ??90
Its gastroscopy effect sees Table 4.Table 4
Superficial gastritis Atrophic gastritis
Two months Two months Six months
Capsules group The electuary group Capsules group The electuary group Capsules group The electuary group
The example number ????14 ????15 ????16 ????15 ????6 ????7
Produce effects ????3 ????3 ????1 ????2 ????1
Effectively ????9 ????9 ????10 ????7 ????4 ????4
Invalid ????2 ????3 ????5 ????6 ????2 ????2
Total effective rate (%) ????85.71 ????80 ????71.42 ????68.75 ????66.67 ????71.42
Through clinical observation more than a year, this preparation is not found side effect, and check routine blood test, liver, renal function etc. do not find that it has infringement to important organs such as the blood system heart, Liver and kidney before and after the treatment.Check table 5 is seen in its safety.
Table 5
The unusual case load of Capsules group The unusual case load of electuary group
Before the treatment After the treatment Before the treatment After the treatment
??HB ????0 ????0 ????0 ????0
??WBC ????0 ????0 ????0 ????0
??RBC ????0 ????0 ????0 ????0
??SGPT ????0 ????0 ????0 ????0
??RUN ????0 ????0 ????0 ????0
??CR ????0 ????0 ????0 ????0
??OB ????0 ????0 ????0 ????0
In sum, this Chinese medicine preparation, no matter be capsule or electuary, treatment YIN-deficiency type chronic superficial gastritis and atrophic gastritis all there are definite curative effect and significant effect, clinical application is extensive, safety, and having no side effect, the curative effect proper extension of YIN-deficiency type atrophic gastritis is more helped to improve curative effect its course of treatment, is the important breakthrough of treatment by Chinese herbs atrophic gastritis.
Embodiment:
Embodiment 1: get Radix Codonopsis 5Kg, Rhizoma Dioscoreae 15kg, Rhizoma Polygonati (steaming) 15kg, Pericarpium Citri Reticulatae 4kg, Rhizoma Zingiberis 1kg, Radix Scrophulariae 5kg, Fructus Mume 16kg, Radix Glehniae 5kg, the Rhizoma Atractylodis Macrocephalae (stir-fry) 5kg, Fructus Crataegi (stir-fry) 5kg, field dobber (decocting a drug wrapped) 5kg.
Production technology is made capsule or electuary dosage form routinely.
Embodiment 2: get Radix Codonopsis 10kg, Rhizoma Dioscoreae 10kg, Rhizoma Polygonati (steaming) 10kg, Pericarpium Citri Reticulatae 8kg, Rhizoma Zingiberis 3kg, Radix Scrophulariae 10kg, Fructus Mume 12kg, Radix Glehniae 10kg, the Rhizoma Atractylodis Macrocephalae (stir-fry) 10kg, Fructus Crataegi (stir-fry) 10kg, field dobber (decocting a drug wrapped) 10kg, production technology is made capsule or electuary dosage form routinely.
Embodiment 3: get Radix Codonopsis 15kg, Rhizoma Dioscoreae 5kg, Rhizoma Polygonati (steaming) 5kg, Pericarpium Citri Reticulatae 12kg, Rhizoma Zingiberis 4kg, Radix Scrophulariae 15kg, Fructus Mume 7kg, Radix Glehniae 15kg, the Rhizoma Atractylodis Macrocephalae (stir-fry) 15kg, Fructus Crataegi (stir-fry) 15kg, field dobber (decocting a drug wrapped) 15kg, connect conventional production process and make capsule or electuary dosage form.

Claims (2)

1, a kind of Chinese medicine preparation for the treatment of deficiency of spleen and stomach Yin type atrophic gastritis is characterized in that its raw material components percentage by weight is:
Radix Codonopsis 5-15 Pericarpium Citri Reticulatae 4-12 Rhizoma Dioscoreae 5-15 Rhizoma Zingiberis 1-5
Radix Scrophulariae 5-15 Fructus Mume 7-16 Radix Glehniae 5-15 Rhizoma Polygonati (steaming) 5-15
The Rhizoma Atractylodis Macrocephalae (stir-fry) 5-15 Fructus Crataegi (stir-fry) 5-15 field dobber (decocting a drug wrapped) 5-15
2,, it is characterized in that described preparation is capsule and two kinds of dosage forms of electuary as weighing 1 described a kind of Chinese medicine preparation.
CN 02113187 2002-06-15 2002-06-15 Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis Ceased CN1242800C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02113187 CN1242800C (en) 2002-06-15 2002-06-15 Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02113187 CN1242800C (en) 2002-06-15 2002-06-15 Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis

Publications (2)

Publication Number Publication Date
CN1387889A true CN1387889A (en) 2003-01-01
CN1242800C CN1242800C (en) 2006-02-22

Family

ID=4742493

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02113187 Ceased CN1242800C (en) 2002-06-15 2002-06-15 Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis

Country Status (1)

Country Link
CN (1) CN1242800C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102824549A (en) * 2012-09-24 2012-12-19 周国生 Traditional Chinese medicine for treating stomach-Yin deficiency
CN103157076A (en) * 2011-12-13 2013-06-19 韩兴霞 Traditional Chinese medicine preparation for treatment of chronic gastritis
CN105435202A (en) * 2016-01-05 2016-03-30 段希福 Medicinal preparation for treating gastritis and purpose thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989957A (en) * 2014-05-14 2014-08-20 张华� Pharmaceutical composition for treating stomach-yin deficiency type chronic gastritis and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103157076A (en) * 2011-12-13 2013-06-19 韩兴霞 Traditional Chinese medicine preparation for treatment of chronic gastritis
CN102824549A (en) * 2012-09-24 2012-12-19 周国生 Traditional Chinese medicine for treating stomach-Yin deficiency
CN102824549B (en) * 2012-09-24 2014-05-07 南阳医学高等专科学校 Traditional Chinese medicine for treating stomach-Yin deficiency
CN105435202A (en) * 2016-01-05 2016-03-30 段希福 Medicinal preparation for treating gastritis and purpose thereof

Also Published As

Publication number Publication date
CN1242800C (en) 2006-02-22

Similar Documents

Publication Publication Date Title
CN103405701A (en) Medicine for treating gastrointestinal diseases and preparation method thereof
CN102078462A (en) Asthma relieving medicament
CN102488846B (en) Medicinal composition for treating diabetes mellitus
CN102210818B (en) Chinese medicine for treating gastrorrhagia
CN1213760C (en) Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis
CN100553673C (en) The Chinese patent medicine of treatment chronic pharyngitis
CN1367003A (en) Medicine for curing AIDS
CN101874850B (en) Medicament for treating chronic urticaria
CN1242800C (en) Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis
CN111588757A (en) Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease in stable phase and preparation method thereof
CN103479947B (en) The preparation method of control constipation medicine
CN103751745A (en) Traditional Chinese medicine for treating urticaria
CN101979061A (en) Antiemetic medicine
CN1207021C (en) Chinese patent medicine for curing gastropathy
CN101979035A (en) Medicament for treating gynecological abnormal leucorrhea
CN102836407B (en) Medicament for treating chronic colitis
CN101979056A (en) Traditional Chinese medicament for treating asthma
CN102824461A (en) Medicine for treating hypertension and preparation method thereof
CN107582831A (en) It is a kind of effectively to alleviate gaseous distention and the Chinese medicine composition of hiccup
CN113230379B (en) Qi-regulating and lump-relieving decoction for treating gastroparesis syndrome after abdominal tumor surgery
CN101766745A (en) Medicine for treating gastritis and preparation method
CN100540043C (en) A kind of treatment hypertension drug
CN107773625A (en) A kind of relieving cough and asthma Chinese medicinal decoction
CN104127557A (en) Traditional Chinese medicine for treating liver cirrhosis
CN106822515A (en) One kind treats the dyspeptic Traditional chinese medicine medicament formula of liver-stomach disharmony type

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Xuan Shengyi

Document name: Notification to Pay the Fees

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060222

Termination date: 20100615

C35 Partial or whole invalidation of patent or utility model
IW01 Full invalidation of patent right

Decision date of declaring invalidation: 20101215

Decision number of declaring invalidation: 15735

Granted publication date: 20060222